These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25205743)

  • 1. NPY antagonism reduces adiposity and attenuates age-related imbalance of adipose tissue metabolism.
    Park S; Fujishita C; Komatsu T; Kim SE; Chiba T; Mori R; Shimokawa I
    FASEB J; 2014 Dec; 28(12):5337-48. PubMed ID: 25205743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor.
    Yang K; Guan H; Arany E; Hill DJ; Cao X
    FASEB J; 2008 Jul; 22(7):2452-64. PubMed ID: 18323405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38α function in osteoblasts influences adipose tissue homeostasis.
    Rodríguez-Carballo E; Gámez B; Méndez-Lucas A; Sánchez-Freutrie M; Zorzano A; Bartrons R; Alcántara S; Perales JC; Ventura F
    FASEB J; 2015 Apr; 29(4):1414-25. PubMed ID: 25550462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y resists excess loss of fat by lipolysis in calorie-restricted mice: a trait potential for the life-extending effect of calorie restriction.
    Park S; Komatsu T; Kim SE; Tanaka K; Hayashi H; Mori R; Shimokawa I
    Aging Cell; 2017 Apr; 16(2):339-348. PubMed ID: 28101970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double deletion of orexigenic neuropeptide Y and dynorphin results in paradoxical obesity in mice.
    Nguyen AD; Slack K; Schwarzer C; Lee NJ; Boey D; Macia L; Yulyaningsih E; Enriquez RF; Zhang L; Lin S; Shi YC; Baldock PA; Herzog H; Sainsbury A
    Neuropeptides; 2014 Jun; 48(3):143-51. PubMed ID: 24680736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis.
    Allison SJ; Baldock PA; Enriquez RF; Lin E; During M; Gardiner EM; Eisman JA; Sainsbury A; Herzog H
    J Bone Miner Res; 2009 Feb; 24(2):294-304. PubMed ID: 18847327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular mechanisms coupled to NPY Y2 and Y5 receptor activation and lipid accumulation in murine adipocytes.
    Rosmaninho-Salgado J; Cortez V; Estrada M; Santana MM; Gonçalves A; Marques AP; Cavadas C
    Neuropeptides; 2012 Dec; 46(6):359-66. PubMed ID: 22981159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central and peripheral mechanisms of the NPY system in the regulation of bone and adipose tissue.
    Shi YC; Baldock PA
    Bone; 2012 Feb; 50(2):430-6. PubMed ID: 22008645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M; Ghibaudi L; Gao J; Hwa JJ
    Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NPY Deficiency Prevents Postmenopausal Adiposity by Augmenting Estradiol-Mediated Browning.
    Park S; Nayantai E; Komatsu T; Hayashi H; Mori R; Shimokawa I
    J Gerontol A Biol Sci Med Sci; 2020 May; 75(6):1042-1049. PubMed ID: 30561530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y impairs insulin-stimulated translocation of glucose transporter 4 in 3T3-L1 adipocytes through the Y1 receptor.
    Gericke MT; Schröder T; Kosacka J; Nowicki M; Klöting N; Spanel-Borowski K
    Mol Cell Endocrinol; 2012 Jan; 348(1):27-32. PubMed ID: 21801810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
    Lee MS; Kim CT; Kim Y
    Ann Nutr Metab; 2009; 54(2):151-7. PubMed ID: 19390166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice.
    Patel HR; Qi Y; Hawkins EJ; Hileman SM; Elmquist JK; Imai Y; Ahima RS
    Diabetes; 2006 Nov; 55(11):3091-8. PubMed ID: 17065347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic expression of Neuronatin potentiates adipogenesis through enhanced phosphorylation of cAMP-response element-binding protein in 3T3-L1 cells.
    Suh YH; Kim WH; Moon C; Hong YH; Eun SY; Lim JH; Choi JS; Song J; Jung MH
    Biochem Biophys Res Commun; 2005 Nov; 337(2):481-9. PubMed ID: 16223607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression.
    Rosmaninho-Salgado J; Marques AP; Estrada M; Santana M; Cortez V; Grouzmann E; Cavadas C
    Peptides; 2012 Sep; 37(1):49-54. PubMed ID: 22819773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y mediates glucocorticoid-induced osteoporosis and marrow adiposity in mice.
    Wang FS; Lian WS; Weng WT; Sun YC; Ke HJ; Chen YS; Ko JY
    Osteoporos Int; 2016 Sep; 27(9):2777-2789. PubMed ID: 27080706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central neuropeptide Y infusion and melanocortin 4 receptor antagonism inhibit thyrotropic function by divergent pathways.
    Preston E; Cooney GJ; Wilks D; Baran K; Zhang L; Kraegen EW; Sainsbury A
    Neuropeptides; 2011 Dec; 45(6):407-15. PubMed ID: 21862125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mice overexpressing neuropeptide Y in noradrenergic neurons: a novel model of increased adiposity and impaired glucose tolerance.
    Ruohonen ST; Pesonen U; Moritz N; Kaipio K; Röyttä M; Koulu M; Savontaus E
    Diabetes; 2008 Jun; 57(6):1517-25. PubMed ID: 18276767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice.
    Harada K; Shen WJ; Patel S; Natu V; Wang J; Osuga J; Ishibashi S; Kraemer FB
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1182-95. PubMed ID: 12954598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y Y1 receptor knockdown can modify glutathione peroxidase and c-AMP response element-binding protein in phenylpropanolamine-treated rats.
    Hsieh YS; Chen PN; Kuo MH; Kuo DY
    Arch Toxicol; 2013 Mar; 87(3):469-79. PubMed ID: 23052195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.